QuiaPEG

Newsroom

Page:
12345
June 29, 2018

The shareholders of QuiaPEG Pharmaceuticals Holding AB (publ) have held an extraordinaryshareholders’meeting on June 29, 2018.The shareholders’ meeting resolved to, among othersthings, in accordance with the board ofdirectors’proposal, introduce an incentive program by way of issue of a maximum of 1 000 000 warrants to the wholly-owned subsidiary QuiaPEG Pharmaceuticals AB and to authorize the transfer of such warrants to management and others key personnel in the company and its subsidiary. The warrants are issued without consideration.

June 23, 2018

The Shareholders of QuiaPEG Pharmaceuticals Holding AB (publ) have held an Annual General Meeting on June 18, 2018.

June 23, 2018

The shareholders of QuiaPEG Pharmaceuticals Holding AB, org.nr 556658-0196, are hereby given notice to attend the Annual General Meeting to be held on June 29, 2018 10:00 a.m. at MAQS Advokatbyrå, Mäster Samuelsgatan 20 in Stockholm. Registration to the annual general meeting starts at 09:30 a.m.

May 28, 2018

QuiaPEG Pharmaceuticals Holding AB (publ) receives a so-called "Notice of Allowance" regarding granting of a patent in Europe.

Page:
12345
Contact
QuiaPEG Pharmaceuticals Holding AB

Virdings Allé 32 B
754 54 Uppsala
Sweden
+46 (0) 70 693 12 53
info@quiapeg.com

User terms & privacy policy
Send a message